APA (7th ed.) Citation

N, S., P, G., UE, M., ME, S., AM, O., & JL, B. (2023). Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians. ACR open rheumatology, 5(6), 305. https://doi.org/10.1002/acr2.11552

Chicago Style (17th ed.) Citation

N, Singh, Grivas P, Makris UE, Suarez-Almazor ME, O'Hare AM, and Barton JL. "Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians." ACR Open Rheumatology 5, no. 6 (2023): 305. https://doi.org/10.1002/acr2.11552.

MLA (9th ed.) Citation

N, Singh, et al. "Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians." ACR Open Rheumatology, vol. 5, no. 6, 2023, p. 305, https://doi.org/10.1002/acr2.11552.